BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND ITK, PSCTK2, 3702, Q08881, ENSG00000113263, EMT, MGC126258, LYK, MGC126257 AND Diagnosis
132 results:

  • 1. Unraveling the molecular mechanisms of lymph node metastasis in ovarian cancer: focus on MEOX1.
    Li J; Sun Y; Zhi X; Sun Y; Abudousalamu Z; Lin Q; Li B; Yao L; Chen M
    J Ovarian Res; 2024 Mar; 17(1):61. PubMed ID: 38486335
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Fundamental insights and molecular interactions in pancreatic cancer: Pathways to therapeutic approaches.
    Gu M; Liu Y; Xin P; Guo W; Zhao Z; Yang X; Ma R; Jiao T; Zheng W
    Cancer Lett; 2024 Apr; 588():216738. PubMed ID: 38401887
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Characterization of a germline variant TNS1 c.2999-1G > C in a hereditary cancer syndrome family.
    Di X; Wang D; Wu J; Zhu X; Wang Y; Yan J; Wen L; Jiang H; Wen D; Shu B; Zhang S
    Gene; 2024 May; 908():148304. PubMed ID: 38387708
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Exosomal non-coding RNA: A new frontier in diagnosing and treating pancreatic cancer: A review.
    Sha G; Zhang W; Jiang Z; Zhao Q; Wang D; Tang D
    Int J Biol Macromol; 2024 Apr; 263(Pt 1):130149. PubMed ID: 38365161
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. FOXA2-initiated transcriptional activation of INHBA induced by methylmalonic acid promotes pancreatic neuroendocrine neoplasm progression.
    Hu C; Ye M; Bai J; Liu P; Lu F; Chen J; Xu Y; Yan L; Yu P; Xiao Z; Gu D; Xu L; Tian Y; Tang Q
    Cell Mol Life Sci; 2024 Jan; 81(1):50. PubMed ID: 38252148
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. CMTM 6 promotes the development of thyroid cancer by inhibiting NIS activity through activating the MAPK signaling pathway.
    Chen X; Shen H; Liu H; Tan L; Zhang N
    Funct Integr Genomics; 2024 Jan; 24(1):10. PubMed ID: 38221563
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. IRS1 promotes thyroid cancer metastasis through emt and PI3K/AKT pathways.
    Yu F; Huang D; Kuang Y; Dong J; Han Q; Zhou J; Teng X
    Clin Endocrinol (Oxf); 2024 Mar; 100(3):284-293. PubMed ID: 38172081
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. HOXD9/miR-451a/PSMB8 axis is implicated in the regulation of cell proliferation and metastasis via PI3K/AKT signaling pathway in human anaplastic thyroid carcinoma.
    Zhong Y; Yu F; Yang L; Wang Y; Liu L; Jia C; Cai H; Yang J; Sheng S; Lv Z; Weng L; Wu B; Zhang X
    J Transl Med; 2023 Nov; 21(1):817. PubMed ID: 37974228
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. ARID5B promoted the histone demethylation of SORBS2 and hampered the metastasis of ovarian cancer.
    Deng Y; Dong Y; Wu L; Zhang Q; Yang L
    Pathol Res Pract; 2023 Dec; 252():154911. PubMed ID: 37948999
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. miR-29c-3p acts as a tumor promoter by regulating β-catenin signaling through suppressing DNMT3A, TET1 and HBP1 in ovarian carcinoma.
    Zhao H; Feng L; Cheng R; Wu M; Bai X; Fan L; Liu Y
    Cell Signal; 2024 Jan; 113():110936. PubMed ID: 37925048
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Targeting doublecortin-like kinase 1 reveals a novel strategy to circumvent chemoresistance and metastasis in ovarian cancer.
    Dogra S; Elayapillai SP; Qu D; Pitts K; Filatenkov A; Houchen CW; Berry WL; Moxley K; Hannafon BN
    Cancer Lett; 2023 Dec; 578():216437. PubMed ID: 37838282
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Disabled-2: a protein up-regulated by high molecular weight hyaluronan has both tumor promoting and tumor suppressor roles in ovarian cancer.
    Price ZK; Lokman NA; Sugiyama M; Koya Y; Yoshihara M; Oehler MK; Kajiyama H; Ricciardelli C
    Cell Mol Life Sci; 2023 Oct; 80(11):320. PubMed ID: 37815603
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. High-Fat Mouse Model to Explore the Relationship between Abnormal Lipid Metabolism and Enolase in Pancreatic cancer.
    Qin L; Sun K; Shi L; Xu Y; Zhang R
    Mediators Inflamm; 2023; 2023():4965223. PubMed ID: 37731842
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Hypoxic papillary thyroid carcinoma cells-secreted exosomes deliver miR-221-3p to normoxic tumor cells to elicit a pro-tumoral effect by regulating the ZFAND5.
    Yu F; Deng X; Zhong Y; Guo B; Zhang X; Wu B
    Exp Cell Res; 2023 Oct; 431(1):113716. PubMed ID: 37488006
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Machine learning-assisted analysis of epithelial mesenchymal transition pathway for prognostic stratification and immune infiltration assessment in ovarian cancer.
    Li Q; Xiao X; Feng J; Yan R; Xi J
    Front Endocrinol (Lausanne); 2023; 14():1196094. PubMed ID: 37404304
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. The Role of emt-Related lncRNAs in Ovarian cancer.
    Lampropoulou DI; Papadimitriou M; Papadimitriou C; Filippou D; Kourlaba G; Aravantinos G; Gazouli M
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373222
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. GABRP Promotes the Metastasis of Pancreatic cancer by Activation of the MEK/ERK Signaling Pathway.
    Meng Y; Li R; Geng S; Chen W; Jiang W; Li Z; Hao J; Xu Z
    Biochem Genet; 2024 Feb; 62(1):242-253. PubMed ID: 37326897
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The potential role of miRNAs in the pathogenesis of testicular germ cell tumors - A Focus on signaling pathways interplay.
    Doghish AS; Moustafa HAM; Elballal MS; Sallam AM; El-Dakroury WA; Abdel Mageed SS; Elesawy AE; Abdelmaksoud NM; Shahin RK; Midan HM; Elrebehy MA; Elazazy O; Nassar YA; Elazab IM; Elballal AS; Elballal MS; Abulsoud AI
    Pathol Res Pract; 2023 Aug; 248():154611. PubMed ID: 37315401
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. SOX9/NFIA promotes human ovarian cancer metastasis through the Wnt/β-catenin signaling pathway.
    Lu R; Tang P; Zhang D; Lin S; Li H; Feng X; Sun M; Zhang H
    Pathol Res Pract; 2023 Aug; 248():154602. PubMed ID: 37315400
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Notch signaling pathway in pancreatic tumorigenesis.
    Chung WC; Xu K
    Adv Cancer Res; 2023; 159():1-36. PubMed ID: 37268393
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 7.